Idioma:

Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death: The ALPHEE Study

KOWEY, Peter R ; CRIJNS, Harry J. G. M ; ALIOT, Etienne M ; CAPUCCI, Alessandro ; KULAKOWSKI, Piotr ; RADZIK, David ; ROY, Denis ; CONNOLLY, Stuart J ; HOHNLOSER, Stefan H

Circulation (New York, N.Y.), 2011-12, Vol.124 (24), p.2649-2660 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por

Enviar para

Título:
Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death: The ALPHEE Study
Autor: KOWEY, Peter R ; CRIJNS, Harry J. G. M ; ALIOT, Etienne M ; CAPUCCI, Alessandro ; KULAKOWSKI, Piotr ; RADZIK, David ; ROY, Denis ; CONNOLLY, Stuart J ; HOHNLOSER, Stefan H
Assuntos: Aged ; Amiodarone - therapeutic use ; Anti-Arrhythmia Agents - therapeutic use ; Benzofurans - therapeutic use ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology ; Cardiology. Vascular system ; Cardiovascular system ; Death, Sudden, Cardiac - epidemiology ; Death, Sudden, Cardiac - prevention & control ; Defibrillators, Implantable ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Humans ; Incidence ; Kaplan-Meier Estimate ; Kardiologi ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Tachycardia, Ventricular - epidemiology ; Tachycardia, Ventricular - prevention & control ; Tachycardia, Ventricular - therapy ; Treatment Outcome ; Vascular wall ; Ventricular Fibrillation - epidemiology ; Ventricular Fibrillation - prevention & control ; Ventricular Fibrillation - therapy
É parte de: Circulation (New York, N.Y.), 2011-12, Vol.124 (24), p.2649-2660
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-News-2
ObjectType-Feature-3
Descrição: Celivarone is a new antiarrhythmic agent developed for the treatment of ventricular arrhythmias. This study investigated the efficacy and safety of celivarone in preventing implantable cardioverter-defibrillator (ICD) interventions or death. Celivarone (50, 100, or 300 mg/d) was assessed compared with placebo in this randomized, double-blind, placebo-controlled, parallel-group study. Amiodarone (200 mg/d after loading dose of 600 mg/d for 10 days) was used as a calibrator. A total of 486 patients with a left ventricular ejection fraction ≤40% and at least 1 ICD intervention for ventricular tachycardia or ventricular fibrillation in the previous month or ICD implantation in the previous month for documented ventricular tachycardia/ventricular fibrillation were randomized. Median treatment duration was 9 months. The primary efficacy end point was occurrence of ventricular tachycardia/ventricular fibrillation-triggered ICD interventions (shocks or antitachycardia pacing) or sudden death. The proportion of patients experiencing an appropriate ICD intervention or sudden death was 61.5% in the placebo group; 67.0%, 58.8%, and 54.9% in the celivarone 50-, 100-, and 300-mg groups, respectively; and 45.3% in the amiodarone group. Hazard ratios versus placebo for the primary end point ranged from 0.860 for celivarone 300 mg to 1.199 for celivarone 50 mg. None of the comparisons versus placebo were statistically significant. Celivarone had an acceptable safety profile. Celivarone was not effective for the prevention of ICD interventions or sudden death. http://www.clinicaltrials.gov. Unique identifier: NCT00993382.
Editor: Hagerstown, MD: Lippincott Williams & Wilkins
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death: The ALPHEE Study

KOWEY, Peter R ; CRIJNS, Harry J. G. M ; ALIOT, Etienne M ; CAPUCCI, Alessandro ; KULAKOWSKI, Piotr ; RADZIK, David ; ROY, Denis ; CONNOLLY, Stuart J ; HOHNLOSER, Stefan H

Hagerstown, MD: Lippincott Williams & Wilkins

Buscando em bases de dados remotas. Favor aguardar.